In an otherwise healthy adult with acute low back pain and no red‑flag features, is mefenamic acid appropriate, and what dosing and monitoring are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mefenamic Acid for Acute Low Back Pain

Mefenamic acid is an appropriate NSAID option for acute low back pain in otherwise healthy adults, but it offers no specific advantage over other NSAIDs and should be used at the lowest effective dose (500 mg initial, then 250 mg every 6 hours) for the shortest duration necessary—typically not exceeding one week.

Evidence-Based Recommendation

The American College of Physicians/American Pain Society guidelines establish that NSAIDs are first-line pharmacologic options for acute low back pain 1. Mefenamic acid, as a nonselective NSAID, falls within this evidence-based recommendation. However, the guidelines do not single out mefenamic acid as superior to other NSAIDs—the evidence shows NSAIDs as a class provide moderate pain relief (10-20 points on a 100-point visual analogue scale) 1.

Specific Dosing Protocol

According to FDA labeling, for acute pain in adults:

  • Initial dose: 500 mg
  • Maintenance: 250 mg every 6 hours as needed
  • Duration: Usually not to exceed one week 2

This time-limited approach aligns with guideline recommendations to use "the lowest effective doses for the shortest periods necessary" 1.

Clinical Context and Comparative Effectiveness

One older comparative trial found mefenamic acid 1500 mg daily performed consistently well against other analgesics for acute low back pain exacerbations, with significantly lower pain scores than paracetamol or dextropropoxyphene combinations 3. However, this evidence is limited and dated. More recent systematic reviews confirm NSAIDs are effective for acute/subacute low back pain but don't demonstrate clear superiority of one NSAID over another 4, 5, 6.

The key point: acetaminophen alone is now known to be ineffective for acute low back pain 4, making NSAIDs like mefenamic acid a more evidence-based choice than previously thought.

Mandatory Risk Assessment Before Prescribing

Before prescribing mefenamic acid, you must assess:

Cardiovascular Risk Factors

  • History of myocardial infarction, stroke, or cardiovascular disease
  • Hypertension, hyperlipidemia, diabetes
  • All NSAIDs (both nonselective and COX-2 selective) are associated with increased MI risk 1

Gastrointestinal Risk Factors

  • History of peptic ulcer disease or GI bleeding
  • Age >65 years
  • Concurrent corticosteroid or anticoagulant use
  • Consider co-prescribing a proton-pump inhibitor in higher-risk patients 1

Renal Function

  • Pre-existing renal disease is a contraindication
  • NSAIDs carry renovascular risks 1
  • Mefenamic acid should not be used in significantly impaired renal function 2

Hepatic Function

  • Assess baseline liver function
  • Mefenamic acid is metabolized by CYP2C9 2

Monitoring Requirements

  • No routine laboratory monitoring is required for short-term use (<1 week)
  • For any extended use beyond one week (which should be exceptional), reassess pain control and consider alternative therapies 1
  • Watch for signs of GI bleeding, cardiovascular events, or renal dysfunction

Critical Pitfalls to Avoid

  1. Do NOT extend treatment beyond one week without reassessment—the evidence supports only short-term benefits 1, 4

  2. Do NOT combine with other NSAIDs—this increases risk without improving efficacy

  3. Do NOT use in patients with contraindications to NSAIDs (active GI bleeding, severe renal impairment, aspirin-sensitive asthma)

  4. Do NOT prescribe without advising patients to stay active—72% of ED physicians incorrectly recommend activity restrictions, which contradicts guidelines 7

  5. Avoid the temptation to order imaging—unless red flags are present, imaging is not indicated and represents low-value care 7

Alternative Considerations

If mefenamic acid is contraindicated or ineffective:

  • Other NSAIDs (ibuprofen, naproxen) have equivalent evidence 1, 6
  • Skeletal muscle relaxants can be added for short-term relief but cause sedation 1
  • Opioids should be reserved for severe, disabling pain uncontrolled by NSAIDs 1

Practical Algorithm

  1. Confirm no red flags (cauda equina, fracture, infection, malignancy)
  2. Assess cardiovascular, GI, and renal risk factors
  3. If low risk: Prescribe mefenamic acid 500 mg initial dose, then 250 mg q6h PRN
  4. Add PPI if GI risk factors present
  5. Advise patient to remain active and avoid bed rest
  6. Limit prescription to 7 days maximum
  7. If pain persists beyond 4 weeks, reassess and consider non-pharmacologic therapies (spinal manipulation) 1

The evidence is clear: mefenamic acid works for acute low back pain as well as other NSAIDs, but the real clinical skill lies in appropriate patient selection, risk mitigation, and time-limited use 1, 4.

Related Questions

What oral and intravenous medication regimens, including dose, formulation, and duration, are recommended for treating shoulder contracture and acute low back pain, and what alternatives should be used in patients with NSAID allergy?
For a 36-year-old male with a two-week history of uncomplicated low back pain and no red-flag findings, should initial management be a trial of oral meloxicam, a lidocaine 5% patch, or transcutaneous electrical nerve stimulation (TENS) without lumbar imaging?
What is the appropriate imaging for acute low back pain with radiculopathy in the Emergency Department (ED)?
How should I draft an urgent emergency department interconsultation for a young adult with a 7‑day history of severe lumbar radicular pain radiating to the right lower extremity, no neurological deficits, and requiring intravenous ketorolac and urgent thoracolumbar MRI?
What is the recommended moderate adult dose of mefenamic acid and what precautions should be considered?
Does a simple renal cyst require referral to nephrology?
In a patient with bipolar disorder currently taking lamotrigine 100 mg daily who recently ran out of medication and is ambivalent about continuation, should the lamotrigine dose be increased to 150 mg?
What medications are appropriate for treating brain disorders or improving brain health?
In a male patient on testosterone therapy with a hematocrit of 53.9%, how many standard whole‑blood donations are required to reduce the hematocrit to 49%?
In patients with dementia, does administering antipsychotics in lower, more frequent doses reduce the black‑box warning‑related risks compared with a single larger daily dose?
How do proton pump inhibitors (PPIs) lead to increased eosinophilia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.